Cited by 773PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and CancerAdvanced Breast Cancer Therapies

The DOI matches its Crossref record; 129 of the 131 references it cites were found in a registry or an index.

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway

Polivka, Jiri, Janku, Filip·2014·Pharmacology & Therapeutics

DOI 10.1016/j.pharmthera.2013.12.004

Open this paper in CoChat — free account

Abstract

Aberrations in various cellular signaling pathways are instrumental in regulating cellular metabolism, tumor development, growth, proliferation, metastasis and cytoskeletal reorganization. The fundamental cellular signaling cascade involved in these processes, the phosphatidylinositol 3-kinase/protein kinase-B/mammalian target of rapamycin (PI3K/AKT/mTOR), closely related to the mitogen-activated protein kinase (MAPK) pathway, is a crucial and intensively explored intracellular signaling pathway in tumorigenesis. Various activating mutations in oncogenes together with the inactivation of tumor suppressor genes are found in diverse malignancies across almost all members of the pathway. Substantial progress in uncovering PI3K/AKT/mTOR alterations and their roles in tumorigenesis has enabled the development of novel targeted molecules with potential for developing efficacious anticancer treatment. Two approved anticancer drugs, everolimus and temsirolimus, exemplify targeted inhibition of PI3K/AKT/mTOR in the clinic and many others are in preclinical development as well as being tested in early clinical trials for many different types of cancer. This review focuses on targeted PI3K/AKT/mTOR signaling from the perspective of novel molecular targets for cancer therapy found in key pathway members and their corresponding experimental therapeutic agents. Various aberrant prognostic and predictive biomarkers are also discussed and examples are given. Novel approaches to PI3K/AKT/mTOR pathway inhibition together with a better understanding of prognostic and predictive markers have the potential to significantly improve the future care of cancer patients in the current era of personalized cancer medicine.

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2013.12.004

Cites

129 of 129 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Hudes, G. R., Carducci, M. A., Tomczak, P., Dutcher, J. P., Figlin, R. A., Kapoor, A., Starosławska, E., Sosman, J. A., McDermott, D. F., Bodrogi, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066838 · Cited by 3,645
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
Motzer, R. J., Escudier, B., Oudard, S., Hutson, T. E., Porta, C., Bracarda, S., Grünwald, V., Thompson, J. A., Figlin, R. A., Hollaender, N., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61039-9 · Cited by 3,019
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
Yao, J. C., Shah, M. H., Ito, T., Lombard‐Bohas, C., Wolin, E. M., Cutsem, E. V., Hobday, T. J., Okusaka, T., Capdevila, J., de Vries, E. G. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009290 · Cited by 2,879

Show all 131 references

Research works printed but not linked: 1

Janku, 2011, Loss of PTEN expression in patients treated with PI3K/AKT/mTOR signaling pathway inhibitors, Cancer Res, 71

Sorted by citations

Items 501–600 of 773

Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer
Luo, F., Zhao, Y., & Liu, J. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105750 · Cited by 11
PIK3CA somatic mutation in sinonasal teratocarcinosarcoma
Belardinilli, F., Vincentiis, L. D., D’Ecclesia, A., Giannini, G., Giangaspero, F., & Corsi, A. (2020) · Auris Nasus Larynx · doi:10.1016/j.anl.2020.03.006 · Cited by 11
A Comprehensive Network Pharmacology‐Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer
Zhuang, Z., Chen, Q., Huang, C., Wen, J., Huang, H., & Liu, Z. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/7658342 · Cited by 11
Transcriptional regulation of MYC through G-quadruplex structures
Balaratnam, S., & Schneekloth, J. S. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.05.002 · Cited by 12
Prenylated flavonoids from Ficus hirta induces HeLa cells apoptosis via MAPK and AKT signaling pathways
Ye, X., Tian, W., Ζhou, M., Zeng, D., Lin, T., Wang, G., Yao, X., & Chen, H. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127859 · Cited by 11
Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial–mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation
Zheng, Y., Xie, L., Xu, S., Yan, W., Zhang, H., Meng, Y., Jingqiao, L., & Wei, X. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04211-4 · Cited by 11
Preparation of emulsions-filled sodium alginate hydrogel beads to enhance the anti-cancer activity of fangchinoline in vivo and in vitro
Liu, C., Wang, M.-X., Lyu, X.-T., Guo, X., Prieto, M. A., Carpena, M., Sun, J., Zhang, K., Lu, C., & Li, N. (2023) · European Polymer Journal · doi:10.1016/j.eurpolymj.2023.112628 · Cited by 10
Radiation‐activated prosurvival signaling pathways in cancer cells
Ouellette, M. M., & Yan, Y. (2019) · Precision Radiation Oncology · doi:10.1002/pro6.1076 · Cited by 10
Discovery of 2-Methyl-2-(4-(2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-6-yl)-1H-naphtho[1,2-d]imidazol-1-yl)phenyl)propanenitrile as a Novel PI3K/mTOR Inhibitor with Enhanced Antitumor Efficacy In Vitro and In Vivo
Yang, J., Liu, Y., Lan, S., Yu, S., Ma, X., Luo, D., Shan, H., Zhong, X.-X., Yan, G., & Li, R. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00572 · Cited by 10
Pseudolaric acid B induces apoptosis associated with the mitochondrial and PI3K/AKT/mTOR pathways in triple‑negative breast cancer
Yang, K., Wang, J., Li, K., Chen, S., & Yu, F. (2023) · Oncology Reports · doi:10.3892/or.2023.8630 · Cited by 10
Glucose-regulated protein 78 contributes to the proliferation and tumorigenesis of human colorectal carcinoma via AKT and ERK pathways
Zhou, X., Xing, X., Zhang, S., Liu, L., Wang, C., Li, L., Ji, Q., & Liu, H. (2016) · Oncology Reports · doi:10.3892/or.2016.5097 · Cited by 10
AS1041, a Novel Synthesized Derivative of Marine Natural Compound Aspergiolide A, Arrests Cell Cycle, Induces Apoptosis, and Inhibits ERK Activation in K562 Cells
Yuan, F., Qiao, L., Chen, Y., Qi, X., Liu, Y., Li, D., Gu, Q., Li, J., & Liu, M. (2017) · Marine Drugs · doi:10.3390/md15110346 · Cited by 10
Virosecurinine induces apoptosis in human leukemia THP‑1 cells and other underlying molecular mechanisms
Zhang, G., Gao, X., Zeng, H., Li, Y., & Guo, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.7437 · Cited by 10
Talin2 regulates invasion of human breast cancer MDA‑MB‑231 cells via alteration of the tumor microenvironment
Wen, Z., Liang, Y., Deng, S., Zou, L., Xie, X., Yang, J., & Wu, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.10175 · Cited by 10
EMX2 is epigenetically silenced and suppresses epithelial‑mesenchymal transition in human esophageal adenocarcinoma
Wang, L., Jin, J. Q., Zhou, Y., Tian, Z., He, B., Huang, Y., & Ding, F. (2019) · Oncology Reports · doi:10.3892/or.2019.7284 · Cited by 10
CBL0137 administration suppresses human hepatocellular carcinoma cells proliferation and induces apoptosis associated with multiple cell death related proteins
Mohd Ali, H., Zhang, P., Chen, H., & Wang, W. (2020) · Neoplasma · doi:10.4149/neo_2020_190621n535 · Cited by 10
Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway
Li, Y., Peng, F., Tan, X., Wang, J., & Xu, Y. (2021) · Genes & Genomics · doi:10.1007/s13258-021-01139-3 · Cited by 9
QSAR, Molecular Docking and Dynamics Studies of Quinazoline Derivatives as Inhibitor of Phosphatidylinositol 3-Kinase
Arba, M., Kalsum, W. U., Alroem, A., Muzakkar, M. Z., Usman, I., & Tjahjono, D. H. (2018) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2018.8501 · Cited by 10
Necrotic cell death caused by exposure to graphitic carbon‐coated magnetic nanoparticles
Kim, J., Sanetuntikul‬, J., Shanmugam, S., & Kim, E. (2015) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35418 · Cited by 10
Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation
Casari, I., Domenichini, A., Sestito, S., Capone, E., Sala, G., Rapposelli, S., & Falasca, M. (2019) · Cancers · doi:10.3390/cancers11111695 · Cited by 10
Uncoupling protein 2 is upregulated in melanoma cells and contributes to the activation of Akt/mTOR and ERK signaling
Li, J., Jia, Y., An, L. K., Niu, C., Cong, X., & Zhao, Y. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5010 · Cited by 9
PKNOX2 suppresses lung cancer cell proliferation by inhibiting the PI3K/AKT/mTOR axis
Song, M., Zhang, N., Cao, F.-M., & Liu, J. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11917 · Cited by 9
TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway
Guo, X., Yin, X., Xu, Y., Li, L., Yuan, M., Zhao, H., Jiang, Y., Shi, X., Bi, H., Liu, Y., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01006-6 · Cited by 9
DNA polymerase ζ suppresses the radiosensitivity of glioma cells by regulating the PI3K/AKT/mTOR pathway
Ding, J., Chen, Z., Ding, W., Xiang, Y., & Yang, J. (2023) · Autoimmunity · doi:10.1080/08916934.2023.2234101 · Cited by 9
Circ-CARD6 inhibits oxidative stress-induced apoptosis and autophagy in ARPE-19 cells via the miR-29b-3p/PRDX6/PI3K/Akt axis
Fan, X., Yang, Y., Wu, G., Kong, Y., Zhang, Y., & Zha, X. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109690 · Cited by 9
Homogeneous Polyporus polysaccharide exerts anti-bladder cancer effects via autophagy induction
Luo, S., Huang, X., Li, S., Chen, Y., Zhang, X., & Zeng, X. Z. (2024) · Pharmaceutical Biology · doi:10.1080/13880209.2024.2316195 · Cited by 9
Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells
Koldehoff, M., Beelen, D. W., & Elmaagacli, A. H. (2014) · Cancer Gene Therapy · doi:10.1038/cgt.2014.27 · Cited by 9
Perspectives in HPV Secondary Screening and Personalized Therapy Basing on Our Understanding of HPV-Related Carcinogenesis Pathways
Celewicz, A., Celewicz, M., Michalczyk, M., & Rzepka, R. (2020) · Mediators of Inflammation · doi:10.1155/2020/2607594 · Cited by 9
Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer
Liang, M.-K., Liang, X.-Q., Zhong, J., Wei, Y., Lian, Z., Huang, Z., & Liang, J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113787 · Cited by 9
Computational Analysis of Drug Resistance Network in Lung Adenocarcinoma
Kara, A., Özgür, A., Teki̇n, Ş., & Tutar, Y. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210218175439 · Cited by 9
A novel SERPINE1‐FOSB fusion gene in pseudomyogenic hemangioendothelioma results in activation of intact FOSB and the PI3K‐AKT‐mTOR signaling pathway and responsiveness to sirolimus
Ren, J., Wang, X., Zhou, Y., Yue, X., Chen, S., Ding, X., Zeng, S., Jiang, X., Liu, X., & Guo, Q. (2021) · The Journal of Dermatology · doi:10.1111/1346-8138.16158 · Cited by 9
Anticancer effects of adenovirus-mediated calreticulin and melanoma-associated antigen 3 expression on non-small cell lung cancer cells
Liu, X., Sun, N., Dong, Y., Li, J., Liu, Y., Ren, Y. L., Yang, C., Zhang, L., Zhou, Y., Tong, Z., et al. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.02.017 · Cited by 9
13-Oxyingenol dodecanoate, a cytotoxic ingenol derivative, induces mitochondrial apoptosis and caspase-dependent Akt decrease in K562 cells
Liu, M., Zhang, W., Wang, G., Song, X., Zhao, X., Wang, X., Qi, X., & Li, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4495-7 · Cited by 9
TFE3/PI3K/Akt/mTOR Axis in Renal Cell Carcinoma Affects Tumor Microenvironment
Hwang, C., Kang, Y. K., Kim, J. Y., Shin, S. H., Park, J. Y., Song, J. S., Kim, S. Y., Jung, S. J., Lee, J. H., Na, J., et al. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.02.022 · Cited by 8
The essential roles of lncRNAs/PI3K/AKT axis in gastrointestinal tumors
Li, P., Ma, X., & Gu, X. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1442193 · Cited by 8
ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT/mTOR Pathway
Qin, X., Liu, M., Xu, C., Xing, B., Xu, X., Wu, Y., Ding, H., & Zhao, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.848952 · Cited by 8
Development of PI3Kγ selective inhibitors: the strategies and application
Gu, D., Zhang, M., Li, J., Zhou, Y., & Sheng, R. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01166-8 · Cited by 8
Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K /Akt/ mTOR signaling pathway
Iranpanah, A., Majnooni, M. B., Biganeh, H., Amirian, R., Rastegari‐Pouyani, M., Filosa, R., Cheang, W. S., Fakhri, S., & Khan, H. Z. (2024) · Phytotherapy Research · doi:10.1002/ptr.8228 · Cited by 8
Treatment-related adverse events in patients with advanced breast cancer receiving adjuvant AKT inhibitors: a meta-analysis of randomized controlled trials
de Moraes, F. C. A., Sano, V. K. T., Pereira, C. R. M., de Laia, E. A., Stecca, C., Magalhães, M. C. F., & Burbano, R. M. R. (2024) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-024-03713-6 · Cited by 8
Targeting protein synthesis pathways in MYC-amplified medulloblastoma
Kumar, D., Kanchan, R. K., & Chaturvedi, N. K. (2025) · Discover Oncology · doi:10.1007/s12672-025-01761-7 · Cited by 9
7‐Deoxynarciclasine shows promising antitumor efficacy by targeting Akt against hepatocellular carcinoma
Yin, S., Qiu, Y., Jin, C., Wang, R. Y., Wu, S., Liu, H., Koo, S., Han, L., Zhang, Y., Gao, X., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32395 · Cited by 8
The NF-κB pathway is critically implicated in the oncogenic phenotype of human osteosarcoma cells
Tan, B., Yuan, Z., Zhang, Q., Xu, X., & Dong, J. (2021) · Journal of Applied Biomedicine · doi:10.32725/jab.2021.021 · Cited by 8
Tumor suppressor LHX6 upregulation contributes to the inhibitory effect of miR ‐346 knockdown on colorectal cancer cell growth
Li, X., Zhou, Y., Wen, P., Yuan, Y., Xiao, Z., Shi, H., & Zhou, H. (2021) · Environmental Toxicology · doi:10.1002/tox.23410 · Cited by 8
Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions
Xu, G., Fang, J., Xu, J., Shen, Z., Huang, C., & Jiang, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.1984719 · Cited by 8
Mechanism of Rhodiola rosea–Euonymus alatus drug pair against rheumatoid arthritis: Network pharmacology and experimental validation
Zheng, Q., Du, L., Zhao, Y., Zhang, Z., Piao, S., Wang, Y., & Pan, Z. J. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.1127 · Cited by 8
Trichomonas vaginalis Metalloproteinase Induces mTOR Cleavage of SiHa Cells
Quan, J., Choi, I.-W., Yang, J.-B., Zhou, W., Cha, G., Zhou, Y., Ryu, J., & Lee, Y. (2014) · Korean Journal of Parasitology · doi:10.3347/kjp.2014.52.6.595 · Cited by 8
Reversal effect of adenovirus-mediated human interleukin 24 transfection on the cisplatin resistance of A549/DDP lung cancer cells
Xu, M., Tang, X., Guo, J., Sun, W., & Tang, F. (2017) · Oncology Reports · doi:10.3892/or.2017.6002 · Cited by 8
Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors
Kim, G., Yoo, M., Hong, M. H., Lee, B., Kang, E. S., Soo, B., Kim, H. R., Lee, Y., & Cho, B. C. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03889-0 · Cited by 8
Dual blocking of PI3K and mTOR signaling by DHW‐221, a novel benzimidazole derivative, exerts antitumor activity in human non‐small cell lung cancer
Qin, X., Liu, M., Wu, Y., Wang, S., Lian, S., Jia, H., Wu, Q., Ding, H., & Zhao, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.514 · Cited by 8
Identification of genes associated with SiHa cell sensitivity to paclitaxel by CRISPR-Cas9 knockout screening.
Wei, W., He, Y., & Wu, Y. (2018) · PubMed Central · Cited by 8
The regulatory role and clinical application prospects of circRNA in the occurrence and development of CNS tumors
Zhang, B., Zhang, H., Wang, Z., Cao, H., Zhang, N., Dai, Z., Liang, X., Peng, Y., Wen, J., Zhang, X., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14500 · Cited by 6
Knockdown of circ_0001883 may inhibit epithelial‑mesenchymal transition in laryngeal squamous cell carcinoma via the miR‑125‑5p/PI3K/AKT axis
Fu, C. S., Lao, Z., Zhang, H., Wang, J., & Wang, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10440 · Cited by 7
Retracted
Targeting T-type channels in cancer: What is on and what is off?
Visa, A., Alza, L., Casas-Benito, A., Herreros, J., & Cantı́, C. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.021 · Cited by 7
Xanthones from Gentianella acuta (Michx.) Hulten Ameliorate Colorectal Carcinoma via the PI3K/Akt/mTOR Signaling Pathway
Lu, M., Ruan, J., Li, H., Yang, D.-S., Liu, Y., Hao, M., Yu, H., Zhang, Y., & Wang, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032279 · Cited by 7
Himalayan flora: targeting various molecular pathways in lung cancer
James, A., Akash, K., Sharma, A. K., Bhattacharyya, S., Sriamornsak, P., Nagraik, R., & Kumar, D. (2023) · Medical Oncology · doi:10.1007/s12032-023-02171-x · Cited by 7
Astaxanthin-loaded PLGA nanoparticles inhibit survival of MKN-45 gastric cancer cell line by modulating JAK2/STAT3/mTOR/PI3K pathway
YektaKooshali, M. H., SobhZahedi, M., Tousi, S. M. T. R., Hamidi, M., & Modiri, L. (2025) · BMC Cancer · doi:10.1186/s12885-024-13401-4 · Cited by 7
Phenotypes associated with inherited and developmental somatic mutations in genes encoding mTOR pathway components
Saxena, A., & Sampson, J. R. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.09.018 · Cited by 7
Brief overview of selected approaches in targeting pancreatic adenocarcinoma
Samore, W. R., & Gondi, C. S. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.902933 · Cited by 7
Involvement of Akt in mitomycin C and its analog triggered cytotoxicity in MCF ‐7 and K562 cancer cells
Cheng, S., Vargas, A., Lee, J., Clement, C. C., & Champeil, É. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13374 · Cited by 7
Knockdown of lncRNA TDRG1 Inhibits Tumorigenesis in Endometrial Carcinoma Through the PI3K/AKT/mTOR Pathway
Sun, R., Sun, X., Liu, H., & Li, P. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s228168 · Cited by 7
Knorpeltumoren: Morphologie, Genetik und Basisaspekte der Targettherapie
Roessner, A., Smolle, M. A., Schoeder, V., & Haybaeck, J. (2020) · Der Pathologe · doi:10.1007/s00292-020-00752-5 · Cited by 7
The protoapigenone analog WYC0209 targets CD133+ cells: A potential adjuvant agent against cancer stem cells in urothelial cancer therapy
Yeh, B., Yu, L.-E., Li, C., Yang, J., Li, W., Wu, Y., Wei, Y., Lee, H., Kung, M., & Wu, W. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115129 · Cited by 7
Actein antagonizes colorectal cancer through blocking PI3K/Akt pathways by downregulating IMPDH2
Yan, L., Wang, D., Liu, X., Gu, C., & Gao, S. (2021) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001080 · Cited by 7
CXCR4 protects bone marrow‑derived endothelial progenitor cells against hypoxia through the PI3K/Akt signaling pathway
Liu, Z., Yang, Q., Cao, Y., Pan, H., Rong, J., Jing, L., Tang, Y., He, J., Wang, C., Peng, X., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10634 · Cited by 7
Expression profile of the PI3K-AKT-mTOR pathway in head and neck squamous cell carcinoma: Data from Brazilian population
Marques, A. E. M., Borges, G. Á., Filho, C., Vianna, L. M. D. S., Ramos, D. D. A. R., CASTILHO, R. M., SQUARIZE, C. H., & Guerra, E. N. S. (2021) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2021.10.020 · Cited by 7
CHMP1A suppresses the growth of renal cell carcinoma cells via regulation of the PI3K/mTOR/p53 signaling pathway
Wu, Y., Wu, Y., Xu, C., Sun, W., You, Z., Wang, Y., & Zhang, S. (2022) · Genes & Genomics · doi:10.1007/s13258-022-01237-w · Cited by 7
CFNC, a neocryptolepine derivative, inhibited the growth of gastric cancer AGS cells by inhibiting PI3K/AKT signaling pathway
Ma, Y., Xu, H., Zhou, Z., Tian, Y., Du, K., Zhang, H., Jiang, X., Lu, J., Niu, Y., Tu, L., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175408 · Cited by 7
Dual PI3K/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU
Zhong, Z., Wang, T., Zang, R., Zang, Y., Feng, Y., Yan, S., Geng, C., Zhu, N., & Wang, Q. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116086 · Cited by 7
Total saponins isolated from Radix et Rhizoma Leonticis suppresses tumor cells growth by regulation of PI3K/Akt/mTOR and p38 MAPK pathways
Zhan, Y., Liu, R., Wang, W., Li, J., Yang, X.-Y., & Zhang, Y. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.10.008 · Cited by 7
Therapeutic Potential of PI3K/Akt/mTOR Signalling Pathway: Effective Combination Therapy for Cancer
Kawade, V., Satpute, P., Dhulap, S. A., & Gurjar, S. (2018) · Indian Journal of Pharmaceutical Sciences · doi:10.4172/pharmaceutical-sciences.1000410 · Cited by 7
Diprophylline inhibits non‑small cell lung cancer A549 cell proliferation and migration, and promotes apoptosis, by downregulating PI3K signaling pathway
Zhao, H., Ren, Y., Ren, X., & Wang, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9678 · Cited by 7
KLHL22 promotes malignant melanoma growth in vitro and in vivo by activating the PI3K/Akt/mTOR signaling pathway
Liu, X., Wang, W., & Li, H. M. (2020) · Neoplasma · doi:10.4149/neo_2020_190923n954 · Cited by 7
The miRNA Profile in Non-Hodgkin’s Lymphoma Patients with Secondary Myelodysplasia
Veryaskina, Y. A., Titov, S. E., Kovynev, I. B., Pospelova, T. I., & Zhimulev, I. F. (2020) · Cells · doi:10.3390/cells9102318 · Cited by 7
Targeting colorectal cancer with Herba Patriniae and Coix seed: Network pharmacology, molecular docking, and in vitro validation
Wang, C.-L., Yang, B.-W., Wang, X., Xue, C., Li, W., Zhai, H.-Y., Wu, Y., Cui, M.-Y., Wu, J., Meng, Q., et al. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i8.3539 · Cited by 6
Network pharmacology combined with molecular docking and experimental validation of the mechanism of action of columbianetin acetate in the treatment of ovarian cancer
Hu, M., Wang, L., Zhang, F., Xie, Y., Zhang, T., Liu, H., Li, Z., & Zhang, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1515976 · Cited by 6
Immune System–Tumor Crosstalk Under Microgravity: Mechanistic Insights, Challenges, and Translational Perspectives
Jasemi, S., Simula, E. R., Lin, Y., Satta, R. R., Rubino, C., Cossu, A., Fais, M., Noli, M., & Sechi, L. A. (2025) · Cancers · doi:10.3390/cancers17172737 · Cited by 6
Synthesis and in-vitro study of a novel ligustrazine diselenide as a potential chemotherapy drug for lung adenocarcinoma
Guo, M., Zhang, E., Wang, G., Ding, R., Xiu-ying, X., Fan, P., Zheng, Y., & Xu, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114699 · Cited by 6
Identification of endoplasmic reticulum stress-related signature characterizes the tumor microenvironment and predicts prognosis in lung adenocarcinoma
Wan, L., Chen, Z., Yang, J., Wu, G., Xu, Y., Cui, J., & Zhao, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-45690-3 · Cited by 6
Integrative analysis of a novel signature incorporating metabolism and stemness-related genes for risk stratification and assessing clinical outcomes and therapeutic responses in lung adenocarcinoma
Zheng, W., Zhou, C., Xue, Z., Qiao, L., Wang, J., & Lu, F. (2025) · BMC Cancer · doi:10.1186/s12885-025-13984-6 · Cited by 6
Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinoma
Watari, K., Nishitani, A., Shibata, T., Noda, M., Kawahara, A., Akiba, J., Murakami, Y., Yano, H., Kuwano, M., & Ono, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10161 · Cited by 6
Towards Enhancing Therapeutic Glycoprotein Bioproduction: Interventions in the PI3K/AKT/mTOR Pathway
Mahameed, M., Sulieman, A., Alkam, D., & Tirosh, B. (2019) · Cell Structure and Function · doi:10.1247/csf.19013 · Cited by 6
In vitro analysis on inhibitory effect of sodium arsenite combined with astragaloside IV on HepG2 liver cancer cells
Guo, Z., Xia, Y., Hao, G., Gao, Z., Li, R., & Yang, Y. (2021) · Alexandria Engineering Journal · doi:10.1016/j.aej.2021.03.043 · Cited by 6
The miR-142 Suppresses U-87 Glioblastoma Cell Growth by Targeting EGFR Oncogenic Signaling Pathway.
Gheidari, F., Arefian, E., Jamshidi‐Adegani, F., Atanaki, F. F., & Soleimani, M. (2021) · PubMed Central · doi:10.22037/ijpr.2021.115089.15193 · Cited by 6
Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma
Xu, H., Chen, G., Niu, Q., Song, K., Feng, Z., & Han, Z. (2022) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2022.06.010 · Cited by 6
ERAP2 as a potential biomarker for predicting gemcitabine response in patients with pancreatic cancer
Yu, P., Luo, S., Cai, J., Li, J., & Peng, C. (2022) · Aging · doi:10.18632/aging.204324 · Cited by 6
Hugan Buzure Induces Autophagy and Apoptosis in Hepatocellular Carcinoma by Inhibiting PI3K/Akt/mTOR Signaling Pathway
Meng, X., Li, M., Qiao, M., Li, X., Yang, J., & Hu, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1618491 · Cited by 6
Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review
Murali, R., & Gopalakrishnan, A. V. (2023) · Medical Oncology · doi:10.1007/s12032-023-02225-0 · Cited by 7
Synthesis and antiproliferative evaluation of novel azido nucleosides and their phosphoramidate derivatives
Xavier, N. M., Gonçalves‐Pereira, R., Jorda, R., Řezníčková, E., Kryštof, V., & Oliveira, M. C. (2017) · Pure and Applied Chemistry · doi:10.1515/pac-2016-1218 · Cited by 6
Long non-coding RNA CRNDE promote the progression of tongue squamous cell carcinoma through regulating the PI3K/AKT/mTOR signaling pathway
Yang, Z., & Chen, W. (2019) · RSC Advances · doi:10.1039/c9ra01321k · Cited by 6
NKAP functions as an oncogene in Ewing sarcoma cells partly through the AKT signaling pathway
Li, F., Wu, J., Wang, P., & Qu, L. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7925 · Cited by 6
Modulation of the PI3K/mTOR pathways
Galstyan, A., Cho, J. M., Johnson, D. E., & Grandis, J. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817868-3.00005-6 · Cited by 6
MCPIP1 expression positively correlates with melanoma‐specific survival of patients, and its overexpression affects vital intracellular pathways of human melanoma cells
Nowak, I., Brożyna, A. A., Zabłocka, M., Student, S., Durbas, M., Bugara, B., & Rokita, H. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23286 · Cited by 6
Cytosolic 5′-Nucleotidase II Silencing in Lung Tumor Cells Regulates Metabolism through Activation of the p53/AMPK Signaling Pathway
Pesi, R., Allegrini, S., Garcia‐Gil, M., Piazza, L., Moschini, R., Jordheim, L. P., Camici, M., & Tozzi, M. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137004 · Cited by 6
Can We Use mTOR Inhibitors for COVID-19 Therapy?
Aneva, I. Y., Kashani, H. R. K., Habtemariam, S., Banach, M., Sil, P. C., Sarkar, K., Sahebnasagh, A., Kamal, M. A., & Khayatkashani, M. (2021) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207325666211130140923 · Cited by 6
Network-guided prediction of aromatase inhibitor response in breast cancer
Ruffalo, M., Thomas, R. A., Chen, J., Lee, A. V., Oesterreich, S., & Bar‐Joseph, Z. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006730 · Cited by 6
Retrospective Assessment of Translational Pharmacokinetic–Pharmacodynamic Modeling Performance: A Case Study with Apitolisib, a Dual PI3K/mTOR Inhibitor
Moein, A., Jin, J. Y., Wright, M. R., Alicke, B., & Wong, H. (2024) · Drugs in R&D · doi:10.1007/s40268-024-00459-5 · Cited by 5
Structural activity of synthesized pyrimidine-thiophene and pyrimidine-thiadiazole conjugates as anticancer agents
Mogadem, A., Bayazeed, A. A., Alrefaei, A. F., Alqarni, S. A., Qurban, J., Bamaga, M. A., El-Zaidia, E. F. M., & El‐Metwaly, N. M. (2024) · Results in Chemistry · doi:10.1016/j.rechem.2024.101813 · Cited by 5
Up-regulation of nPKC contributes to proliferation of mice pulmonary artery smooth muscle cells in hypoxia-induced pulmonary hypertension
Shi, Y., Jiang, R., Qin, X., Gao, A., Hou, X., Chen, L., Xu, X., Guo, Y., Chai, L., Zhao, L., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174046 · Cited by 6
A pyroptosis-related gene signature provides an alternative for predicting the prognosis of patients with hepatocellular carcinoma
Lin, D., Chen, Z., Zeng, Y., Ding, Y., Zhao, L., Xu, Q. Y., Yu, F., Song, X., & Zhu, X. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01431-z · Cited by 5
Polyphyllins in cancer therapy: A systematic review and meta-analysis of animal studies
Bai, Y., Li, M., Geng, D., Liu, S., Chen, Y., Li, S., Zhang, S., & Wang, Z. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155096 · Cited by 5

Authors: Polivka, J., & Janku, F.
Venue: Pharmacology & Therapeutics
Publisher: Elsevier BV
Published: 2014-05
Volume: 142
Issue: 2
Pages: 164-175
ISSN: 0163-7258 (ISSN-L)
DOI: 10.1016/j.pharmthera.2013.12.004
OpenAlex: W2132052921
Cited by: 765
References: 131
Citations by year: 2026: 20 · 2025: 31 · 2024: 41 · 2023: 71 · 2022: 56 · 2021: 90 · 2020: 80 · 2019: 103 · 2018: 63 · 2017: 71 · 2016: 51 · 2015: 59 · 2014: 28
FWCI: 4.39
Type: journal article
Language: en
Open access: closed
Locations: Pharmacology & Therapeutics (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Oncology › Advanced Breast Cancer Therapies
Keywords: PI3K/AKT/mTOR pathway, targeted cancer therapy, molecular targets, PI3K inhibitors, mTOR inhibitors, everolimus, temsirolimus, MAPK signaling, oncogenic mutations, tumor suppressor, prognostic factors, predictive biomarkers, precision oncology, carcinogenesis
MeSH terms: Phosphoinositide-3 Kinase Inhibitors, Animals, Antineoplastic Agents, Humans, Neoplasms, Drug Design, Signal Transduction, Protein Kinase Inhibitors, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinase, TOR Serine-Threonine Kinases, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks